Skip to main content

Table 1 The association between p21 expression and clinicopathological characteristics of studied colonic lesions

From: The association of p21, inhibin, and Tob-1 expression with the clinicopathological characteristics of benign and malignant colorectal lesions

Variables

P21 expression

Positive no. (%)

Negative no. (%)

p-value

Age (in years)

51.43 ± 16.14

54.62 ± 16.45

0.25

Age categories

 

 ≤ 50 years (45)

22 (49)

23 (51)

0.41

 > 50 years (95)

50 (52.6)

45 (47.4)

Sex

 Female (61)

38 (62.3)

23 (37.7)

0.018

 Male (79)

34 (43)

45 (57)

 CRC (30)

12 (40)

18 (60)

 

Type of cancer

 Conventional (21)

10 (47.6)

11 (52.4)

0.19

 Mucinous (9)

2 (22.2)

7 (77.8)

Grade

 Low-grade CRC (13)

6 (46.2)

7 (53.8)

0.41

 High-grade CRC (17)

6 (35.3)

11 (64.7)

Adenomas (30)

15 (50)

15 (50)

0.30*

 LGD (14)

11 (78.6)

3 (21.4)

0.005

 HGD (16)

4 (25)

12 (75)

UC (30)

19 (63.3)

11 (36.7)

0.06*

 No dysplasia (23)

16 (63.3)

7 (30.4)

0.20

 With dysplasia (7)

3 (43)

4 (57)

Chronic colitis (30)

16 (53.3)

14 (46.7)

0.22*

Control (20)

10 (50)

10 (50)

0.34*

Total = 140

72 (51.4)

68 (48.6)

 
  1. LGD low-grade dysplasia, HGD high-grade dysplasia, UC ulcerative colitis, CRC Colorectal cancer, no. number of cases, %; percentage
  2. *p-value compared to CRCs